Biomeme
The Science

Transcriptomics

Your DNA doesn't change. Your gene expression does — every day.

Transcriptomics measures gene expression — the active, changing readout of which genes are turned on or off in your body right now. Unlike static genetic tests, transcriptomic markers respond in real time to medication, disease, stress, and lifestyle.

Explainer

What Is Transcriptomics?

Every cell in your body contains the same DNA — the same 20,000+ protein-coding genes you were born with. But at any given moment, only a fraction of those genes are active. Transcriptomics measures which genes are turned on, how loudly they're expressed, and how those patterns change over time.

When a gene is activated, it produces messenger RNA (mRNA) — the molecular instructions that tell your cells what to build. By measuring mRNA levels, we get a real-time snapshot of your biology in action: which pathways are firing, which are suppressed, and how your body is responding to the world around it.

📖

Genomics

Tells you what recipes are in the cookbook. Your DNA sequence — the full set of instructions, inherited and unchanging.

🍳

Transcriptomics

Tells you which recipes are being prepared right now. Your mRNA expression — dynamic, responsive, changing every day in response to medication, stress, diet, and disease.

🍽️

Proteomics

Tells you what dishes are on the table. Protein levels — the functional output, but harder to measure and slower to change.

The Process

How Transcriptomic Testing Works

From sample to insight — a streamlined pipeline built on isothermal amplification and quantitative PCR — proven methods in molecular measurement.

1

Sample

Blood draw or swab. RNA is stabilized at the point of collection.

2

Extract

RNA is isolated using Biomeme's streamlined prep chemistry.

3

Amplify

RNA targets are reverse-transcribed, amplified, and measured in real-time.

4

Analyze

Expression levels are quantified and compared against reference baselines.

5

Report

Actionable insights delivered via cloud-connected dashboard.

Modalities

Transcriptomics vs. Genomics vs. Proteomics

Three ways to read biology. Only one captures what's happening right now — with the technology Biomeme already has.

Genomics Transcriptomics Proteomics
Measures DNA sequence mRNA expression levels Protein levels
Changes Over Time? Mostly static Yes — dynamic, real-time Yes — but slower
What It Reveals Genetic predisposition Active gene regulation Functional output
Testing Method Sequencing / SNP arrays Isothermal / qPCR / RNA-Seq Mass spectrometry
At Point of Care? Emerging Biomeme's Core Competency No — lab only

Transcriptomics sits at the intersection of what's dynamic and what's measurable in real-time — making it uniquely suited to Biomeme's multiplexed platform.

Capabilities

What Can Transcriptomics Measure?

From immune response to therapeutic monitoring — gene expression reveals what blood chemistry and imaging can't.

Inflammatory Response

Cytokine gene expression (TNFA, IL1B, IL6) reveals the intensity and trajectory of inflammatory pathways — essential for monitoring therapeutic response.

Metabolic Activity

Lipogenesis, insulin signaling, and mitochondrial function — transcriptomic markers capture metabolic shifts days to weeks before they appear in standard blood panels.

Explore GLP-1 & Metabolic Monitoring

Drug Response

Confirm that a therapeutic is engaging its molecular targets. Pharmacodynamic monitoring via gene expression — objective proof the drug is working, not just prescribed.

Immune Status

Distinguish bacterial from viral infections by reading the host immune signature — the foundation of our work in sepsis detection.

Explore Sepsis Diagnostics

Treatment Durability

Longitudinal expression monitoring detects molecular drift — when a treatment starts losing efficacy — before clinical symptoms appear. Early warning, molecular precision.

Environmental Stress

Gene expression signatures for biological exposure, toxin response, and environmental stress markers — critical for biodefense and public health surveillance.

Explore Exposure Monitoring
The Platform

Multiplexed Transcriptomics. Anywhere.

Biomeme is the only platform that can run multiplexed transcriptomic panels at the point of care. Our Biomeme/5 instrument measures up to 48 targets simultaneously — enough for comprehensive gene expression profiling in a single run.

Combined with our streamlined sample prep, cloud-connected software, and CLIA-certified laboratory (One Health Labs), we deliver a complete end-to-end transcriptomic testing solution — from sample to insight.

48
targets per run
<10
minutes to result
CLIA
certified lab
Biodefense CBRN panels
Healthcare Host Response
Wellness GLP-1 Response +
Your Application custom panels

All running on

One Platform · One Instrument · One Lab

Transcriptomic Deep Dives

Explore how gene expression is revolutionizing specific fields of study.

Case Study

GLP-1 Response

GLP-1 receptor agonists trigger massive, systemic shifts in gene expression. Discover why transcriptomics is the key to understanding responder plateaus and metabolic health.

Read the Deep Dive
Case Study

Biological Aging

DNA is chronological. Expression is biological. Learn how transcriptomics provides the ultimate molecular biomarker for cellular senescence and inflammaging.

Read the Deep Dive
Case Study

Athletic Performance

Wearables show physical output; gene expression shows molecular strain. Discover how transcriptomics predicts injury risk and monitors recovery.

Read the Deep Dive
Case Study

Trauma & Sepsis

Predict the crash before it happens. Learn how transcriptomics can detect the host's earliest transcriptional stress signatures — in some studies, 24–48 hours before clinical symptoms of sepsis appear.

Read the Deep Dive
Case Study

Environmental Exposure

Decoding the invisible threat. Learn how transcriptomics measures the active molecular footprint of toxic chemical and radiological exposure before chronic symptoms manifest.

Read the Deep Dive

See Transcriptomics In Action

From monitoring GLP-1 response to distinguishing bacterial infections — explore how Biomeme's platform puts transcriptomic insights where they're needed most.